VanEck Genomics and Healthcare Innovators UCITS ETF

CURE XETRA Santé & Biotech États-Unis
17.73

ETF à effet de levier 3x visant à offrir une exposition renforcée aux actions du secteur de la santé et biotechnologie américaine.

Performance & Momentum

6 Months 7.82 %
1 Year 3.24 %
3 Years 8.53 %
5 Years 17.13 %

Similar stocks to VanEck Genomics and Healthcare Innovators UCITS ETF

Anantys Community

Be the first to share your analysis on VanEck Genomics and Healthcare Innovators UCITS ETF.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases